Scinai Immunotherapeutics(SCNI)
$1.55+0.08 (+5.79%)
SCNI
Scinai Immunotherapeutics financials statements
$1.55
At close:+0.08 (+5.79%)
Want to see SCNI full AI Analyst Report?
Scinai Immunotherapeutics (SCNI) Income Statement
351 Followers
Scinai Immunotherapeutics Income Statement
Last quarter (Q3 2026), Scinai Immunotherapeutics's total revenue was $1.86M, an increase of 589.96% from the same quarter last year. In Q3, Scinai Immunotherapeutics's net income was $-1.97M. See Scinai Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.31M | $ 658.00K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -2.65M | $ -580.00K | $ 0.00 | $ 0.00 | $ -747.65K | |
| $ 4.89M | $ 8.06M | $ 9.71M | $ 11.06M | $ 10.05M | |
| Depreciation and Amortization | $ 1.42M | $ 1.65M | $ 514.00K | $ 562.00K | $ 471.00K |
| $ -6.53M | $ -6.99M | $ -2.19M | $ -5.23M | $ -10.32M | |
| $ -7.54M | $ -8.64M | $ -9.71M | $ -11.06M | $ -10.79M | |
| $ -765.00K | $ 13.43M | $ 3.21M | $ 5.26M | $ -1.58M | |
| $ -8.31M | $ 4.80M | $ -6.50M | $ -5.80M | $ -12.38M | |
| $ -8.31M | $ 4.80M | $ -6.50M | $ -5.80M | $ -12.38M | |
| Per Share Metrics | |||||
| Basic EPS | $ -35.88 | $ 59.88 | $ -165.97 | $ -306.40 | $ -876.87 |
| Diluted EPS | $ -35.88 | $ 59.88 | $ -165.97 | $ -306.40 | $ -876.87 |
| Weighted Average Shares Outstanding | 233.49K | 80.64K | 39.06K | 18.85K | 14.11K |
| Weighted Average Shares Outstanding (Diluted) | 233.49K | 80.64K | 39.06K | 18.85K | 14.11K |
Currency in USD

